Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine

Documents similaires

• Linguistic Validation of the Canine Brief Pain Inventory (CBPI) for Global Use
  par: Jane R. Wells, et autres
  Publié: (2021)
• An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
  par: Kuga A, et autres
  Publié: (2017)
• Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
  par: Watanabe Y, et autres
  Publié: (2018)
• An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
  par: Kuga A, et autres
  Publié: (2017)
• Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
  par: Harada E, et autres
  Publié: (2016)